Enovix (Enovix) Additional Paid-In Capital : $874.53 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Enovix Additional Paid-In Capital?

Enovix's quarterly additional paid-in capital increased from Sep. 2023 ($791.34 Mil) to Dec. 2023 ($857.04 Mil) and increased from Dec. 2023 ($857.04 Mil) to Mar. 2024 ($874.53 Mil).

Enovix's annual additional paid-in capital increased from Dec. 2021 ($659.25 Mil) to Dec. 2022 ($741.19 Mil) and increased from Dec. 2022 ($741.19 Mil) to Dec. 2023 ($857.04 Mil).

Enovix Additional Paid-In Capital Historical Data

The historical data trend for Enovix's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix Additional Paid-In Capital Chart

Enovix Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

243.48

659.25

741.19

857.04

Enovix Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial										770.47	769.98	791.34	857.04	874.53

Enovix Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Enovix Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Enovix's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Enovix (Enovix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

6Q81:Germany 6Q81:Germany

Address

3501 W. Warren Avenue, Fremont, CA, USA, 94538

Website

https://www.enovix.com

Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.

Executives

Rajendra K Talluri	director, officer: President and CEO	3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins	director
Arthi Chakravarthy	officer: See Remarks	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad	officer: Chief Financial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann	director	ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt	officer: Chief Commercial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers	director, 10 percent owner	535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri	officer: Chief Technology Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe	officer: Chief Operating Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust	director, officer: President and CEO	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales	officer: Chief Commercial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p.	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie	director	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek	officer: See Remarks	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538